Pacific Biosciences Partners with Sage Science to Co-market DNA Size Selection Device | GenomeWeb

NEW YORK (GenomeWeb News) − Pacific Biosciences has partnered with Sage Science to co-market Sage's BluePippin DNA size selection device for use with the PacBio RS II single-molecule sequencer, the companies said today.

The BluePippin platform enables users to isolate DNA fragments of a specific length, ranging from 50 bases to 50 kilobases, in an automated way that can then be used to generate next-generation sequencing libraries.

Selecting long DNA fragments for library preparation increases the average read length generated on the PacBio RS II.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions. 

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies. 

Mar
17
Sponsored by
Qiagen

This webinar will discuss Qiagen's approach to address two challenges facing NGS in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.